Long term outcome for onabotulinumtoxinA (Botox) therapy in chronic migraine: A 2-year prospective follow-up audit of patients attending the Hull (UK) migraine clinic
Objective: The objective of this prospective audit was to determine the long term outcome of patients diagnosed with chronic migraine who were treated with onabotulinumtoxinA for the prevention of chronic migraine. Background: While long term and real-world studies have confirmed the safety and effi...
Main Authors: | Fayyaz Ahmed, Alina Buture, Taukir Tanvir, Modar Khalil |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2021-01-01
|
Series: | Cephalalgia Reports |
Online Access: | https://doi.org/10.1177/2515816320985443 |
Similar Items
-
Economic consequences of migraine in Sweden and implications for the cost-effectiveness of onabotulinumtoxinA (Botox) for chronic migraine in Sweden and Norway
by: Amanda Hansson-Hedblom, et al.
Published: (2020-08-01) -
OnabotulinumtoxinA for chronic migraine during pregnancy: a real world experience on 45 patients
by: Ho-Tin Wong, et al.
Published: (2020-10-01) -
Cognitive effects of onabotulinumtoxinA in chronic migraine
by: Susan Ho, et al.
Published: (2020-07-01) -
Prediction of patient's response to OnabotulinumtoxinA treatment for migraine
by: Franklin Parrales Bravo, et al.
Published: (2019-02-01) -
Adult Abdominal Migraine Improved by OnabotulinumtoxinA Injections
by: Neal Hermanowicz
Published: (2021-09-01)